z-logo
open-access-imgOpen Access
RUNX2 mutations in Chinese patients with cleidocranial dysplasia
Author(s) -
Yanping Li,
Wei Pan,
Wu Xu,
Nan He,
Xu Chen,
Huan Liu,
L. Darryl Quarles,
HouDe Zhou,
Zhousheng Xiao
Publication year - 2009
Publication title -
mutagenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.723
H-Index - 91
eISSN - 1464-3804
pISSN - 0267-8357
DOI - 10.1093/mutage/gep025
Subject(s) - cleidocranial dysplasia , haploinsufficiency , nonsense mutation , runx2 , genetics , biology , promoter , point mutation , microbiology and biotechnology , mutation , gene , missense mutation , phenotype , transcription factor , gene expression , anatomy , supernumerary
Cleidocranial dysplasia (CCD) is an autosomal dominant bone disease in humans caused by haploinsufficiency of the RUNX2 gene. The RUNX2 has two major isoforms derived from P1 and P2 promoters. Over 90 mutations of RUNX2 have been reported associated with CCD. In our study, DNA samples of nine individuals from three unrelated CCD families were collected and screened for all exons of RUNX2 and 2 kb of P1 and P2 promoters. We identified two point mutations in the RUNX2 gene in Case 1, including a nonsense mutation (c.577C>T) that has been reported previously and a silent substitution (c.240G>A). In vitro studies demonstrated that c.577C>T mutation led to truncated RUNX2 protein production and diminished stimulating effects on mouse osteocalcin promoter activity when compared with full-length Runx2-II and Runx2-I isoforms. These results confirm that loss of function RUNX2 mutation (c.577C>T) in Case 1 family is responsible for its CCD phenotype.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom